Abstract:Graphical Headlights • The FAK suppression of adipocytes causes adipocyte apoptosis and pro‐inflammatory responses to promote M1 macrophage polarisation. • The FAK suppression of adipocytes activates TRAF6/TAK1/NF‐κB signalling pathway to active inflammatory response. • FAK mediates crosstalk between adipose and pancreatic tissues, and the FAK suppression of adipocytes promotes pancreatic β‐cell apoptosis. • The FAK suppression of adipocytes accelerates the pathogenesis of T1D. Background White adipose tissue (WAT) has a key role in maintaining energy balance throughout the body, and their dysfunction take part in the regulation of diabetes mellitus. However, the internal regulatory mechanisms underlying are still unknown. Methods and results We generated adipocyte‐specific FAK KO (FAK‐AKO) mice and investigated their phenotype. The cascade of adipocyte, macrophage in adipocyte tissues, and pancreatic β‐cells were proposed in FAK‐AKO mice and validated by cell line studies using 3T3‐L1, Raw264.7 and Min6. The FAK‐AKO mice exhibited glucose intolerance, reduced adipose tissue mass and increased apoptosis, lipolysis and inflammatory response in adipose tissue. We further demonstrate that adipocyte FAK deletion increases β cell apoptosis and inflammatory infiltrates into islets, which is potentiated if mice were treated with STZ. In the STZ‐induced diabetes model, FAK AKO mice exhibit less serum insulin content and pancreatic β cell area. Moreover, serum pro‐inflammatory factors increased and insulin levels decreased after glucose stimulation in FAK AKO mice. In a parallel vitro experiment, knockdown or inhibition of FAK during differentiation also increased apoptosis, lipolysis and inflammatory in 3T3‐L1 adipocytes, whereas the opposite was observed upon overexpression of FAK. Moreover, coculturing LPS‐treated RAW264.7 macrophages with knockdown FAK of 3T3‐L1 adipocytes increased macrophage pro‐inflammatory response. Furthermore, conditioned medium from above stimulated Min6 cells apoptosis (with or without STZ), whereas the opposite was observed upon overexpression of FAK. Mechanistically, FAK protein interact with TRAF6 in adipocytes and knockdown or inhibition of FAK activated TRAF6/TAK1/NF‐κB signaling, which exacerbates inflammation of adipocytes themselves. Conclusion Adipocyte FAK deletion promotes both adipocyte apoptosis and adipose tissue inflammation. Pro‐inflammatory factors released by the FAK‐null adipose tissue further trigger apoptosis in pancreatic islets induced by the administration of STZ, thereby exacerbating the diabetes mellitus. This study reveals a link between FAK‐mediated adipose inflammation and diabetes mellitus, a mechanism that has not been previously recognized.

Free Fatty Acid Receptor 2, a Candidate Target for Type 1 Diabetes, Induces Cell Apoptosis Through ERK Signaling.

Free Fatty Acid Receptor 1 (FFAR1) As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges

Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction.

Correction: Involvement of Dynamin-Related Protein 1 in Free Fatty Acid-Induced INS-1-Derived Cell Apoptosis

Toll-like Receptor 2/4 Links to Free Fatty Acid-Induced Inflammation and Β-Cell Dysfunction

Free fatty acids accelerate β-cell death in type 1 diabetes

Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.

NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-induced Dysfunction and Apoptosis of Β-Cells Via JNK, P38 MAPK and P53 Pathways.

Fatty acid-mediated signaling as a target for developing type 1 diabetes therapies

Identification of the Key Genes Involved in the Effect of Folic Acid on Endothelial Progenitor Cell Transcriptome of Patients with Type 1 Diabetes

Adipocyte‐specific FAK deletion promotes pancreatic β‐cell apoptosis via adipose inflammatory response to exacerbate diabetes mellitus

Free fatty acid receptors as therapeutic targets for the treatment of diabetes

Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2

The Roles of ATF3, an Adaptive-Response Gene, in High-Fat-Diet-Induced Diabetes and Pancreatic Β-Cell Dysfunction

Novel Phenoxyalkanoic Acid Derivatives as Free Fatty Acid Receptor 4 Agonists for Treating Type 2 Diabetes Mellitus

Synthesis and Biological Evaluation of Phenoxyacetic Acid Derivatives As Novel Free Fatty Acid Receptor 1 Agonists.

Fatty Acid-Induced Lipotoxicity in Pancreatic Beta-Cells During Development of Type 2 Diabetes

FFAR1 Agonism Restores Insulin Secretion in Rodents, Human Islets, and Diabetic Monkeys

Hyperglycemia Activates FGFR1 Via TLR4/c-Src Pathway to Induce Inflammatory Cardiomyopathy in Diabetes

Fas-Associated Factor 1 Promotes Hepatic Insulin Resistance Via JNK Signaling Pathway

High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line